These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. [CEA and TPA in bladder carcinoma]. Latella G; Ciarniello P; Fusco A; Liberti M; Gentile V; De Berardinis E; Von Heland M Minerva Med; 1986 Mar; 77(13):505-6. PubMed ID: 3703342 [No Abstract] [Full Text] [Related]
6. Cancer of the urinary bladder at Kenyatta National Hospital as seen by physicians: a retrospective study (1979-1984). Otieno LS; Mc'Ligeyo SO; Kimani FM East Afr Med J; 1988 Apr; 65(4):224-9. PubMed ID: 3168855 [No Abstract] [Full Text] [Related]
7. [Supravesical urinary diversion--a palliative treatment method for patients with inoperable bladder cancer]. Prokhozhev AIu; Komiakov BK Vestn Khir Im I I Grek; 1998; 157(4):101-2. PubMed ID: 9825452 [TBL] [Abstract][Full Text] [Related]
8. [Current status of diagnosis and therapy of bladder carcinoma]. Matz M Z Arztl Fortbild (Jena); 1982 Sep; 76(18):815-21. PubMed ID: 6184893 [No Abstract] [Full Text] [Related]
9. Small cell carcinoma of the urinary bladder. A clinicopathologic analysis of 64 patients. Montie JE J Urol; 2005 Jun; 173(6):1920-1. PubMed ID: 15879778 [No Abstract] [Full Text] [Related]
10. [Intra-arterial chemotherapy of inoperable bladder tumors]. Kovács J; Engloner L; Wabrosch G Orv Hetil; 1988 Jan; 129(3):131-3. PubMed ID: 2451199 [No Abstract] [Full Text] [Related]
12. Survival from bladder cancer in England and Wales up to 2001. Shah A; Rachet B; Mitry E; Cooper N; Brown CM; Coleman MP Br J Cancer; 2008 Sep; 99 Suppl 1(Suppl 1):S86-9. PubMed ID: 18813272 [No Abstract] [Full Text] [Related]
14. Outcomes in patients with urothelial carcinoma of the bladder with limited pelvic lymph node dissection. Dhar NB; Campbell SC; Zippe CD; Derweesh IH; Reuther AM; Fergany A; Klein EA BJU Int; 2006 Dec; 98(6):1172-5. PubMed ID: 16956353 [TBL] [Abstract][Full Text] [Related]
15. Transitional cell carcinoma of the urinary bladder: a clinicopathological study. Matalka I; Bani-Hani K; Shotar A; Bani Hani O; Bani-Hani I Singapore Med J; 2008 Oct; 49(10):790-4. PubMed ID: 18946612 [TBL] [Abstract][Full Text] [Related]
16. [Results of radical cystectomy for management of invasive bladder cancer with special reference to prognostic factors and quality of life depending on the type of urinary diversion]. Słojewski M Ann Acad Med Stetin; 2000; 46():217-29. PubMed ID: 11712306 [TBL] [Abstract][Full Text] [Related]
17. [Possibilities and limitations of transurethral surgery in carcinoma of the bladder]. Mauermayer W Urologe A; 1973 Mar; 12(2):55-8. PubMed ID: 4121440 [No Abstract] [Full Text] [Related]
18. The clinical value of CYFRA21-1 in bladder cancer patients: Egyptian experience. el-Ahmady O; Halim AB; el-Din AG Anticancer Res; 1999; 19(4A):2603-8. PubMed ID: 10470202 [TBL] [Abstract][Full Text] [Related]
19. Update on Dx and management of bladder cancer. Trump DL Geriatrics; 1982 Jul; 37(7):87-91. PubMed ID: 7200929 [No Abstract] [Full Text] [Related]
20. [The diagnosis and treatment of bladder cancer metastases]. Kariakin OB; Grishin GN; Volodina TV Urol Nefrol (Mosk); 1997; (2):22-5. PubMed ID: 9206877 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]